Enanta Pharmaceuticals
ENTA
#8907
Rank
NZ$0.19 B
Marketcap
$9.21
Share price
-0.38%
Change (1 day)
-66.39%
Change (1 year)

P/S ratio for Enanta Pharmaceuticals (ENTA)

P/S ratio as of April 2025 (TTM): 1.70

According to Enanta Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.01. At the end of 2024 the company had a P/S ratio of 1.91.

P/S ratio history for Enanta Pharmaceuticals from 2013 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20241.91-28.93%
20232.69-77.16%
202211.8-28.54%
202116.598.3%
20208.3227.67%
20196.5112.81%
20185.77-32.86%
20178.60-32.26%
201612.7169.68%
20154.71-38.15%
20147.61-92.1%
201396.3

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
6.44 279.50%๐Ÿ‡บ๐Ÿ‡ธ USA
4.22 148.26%๐Ÿ‡บ๐Ÿ‡ธ USA
11.3 563.56%๐Ÿ‡บ๐Ÿ‡ธ USA
3.41 100.79%๐Ÿ‡บ๐Ÿ‡ธ USA
2.51 47.88%๐Ÿ‡บ๐Ÿ‡ธ USA
4.30 153.07%๐Ÿ‡จ๐Ÿ‡ญ Switzerland